In contrast to EAI045, CH7233163, a promising fourth-generation EGFR-TKI, inhibited growth of NSCLC cells with Del19/T790M/C797S triple EGFR mutants in vitro and in vivo. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.